Animal Drugs, Feeds, and Related Products; Selegiline Hydrochloride Tablets; Correction
other · Food and Drug Administration · Rule · Published 1997-10-23 · Effective 1997-06-27 · 62 FR 55158
Document
Document number
97-28017
Federal Register citation
62 FR 55158
CFR reference
21 CFR 510
Type
Rule
Action
Final rule; correction.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1997-10-23
Effective date
1997-06-27
Abstract
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of June 27, 1997 (62 FR 34631). The document amended the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Deprenyl Animal Health, Inc. The NADA provides for oral use of selegiline hydrochloride tables for dogs for the control of clinical signs associated with uncomplicated pituitary-dependent hyperadrenocorticism. The approved use in dogs was inadvertently omitted from the document. This document corrects that error.